Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| 1 |
Canadian Imperial Bank of Commerce
CM
|
+$637M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$608M |
| 3 |
JPMorgan Chase
JPM
|
+$563M |
| 4 |
Canadian Natural Resources
CNQ
|
+$502M |
| 5 |
Air Products & Chemicals
APD
|
+$389M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$6.76B |
| 2 |
NVIDIA
NVDA
|
+$984M |
| 3 |
Morgan Stanley
MS
|
+$979M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$878M |
| 5 |
Microsoft
MSFT
|
+$871M |
Sector Composition
| 1 | Financials | 19.76% |
| 2 | Technology | 16.78% |
| 3 | Industrials | 8.53% |
| 4 | Healthcare | 7.7% |
| 5 | Consumer Discretionary | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
5026
Neuraxis
NRXS
$24M
| $47K | ﹤0.01% |
15,101
| – | – |
|
5027
Kraneshares MSCI One Belt One Road Index ETF
OBOR
$5.01M
| $47K | ﹤0.01% |
2,250
-335
| -13% | -$7K |
|
5028
Vicarious Surgical
RBOT
$35.4M
| $47K | ﹤0.01% |
5,140
+2,098
| +69% | +$19.2K |
|
5029
Summit Therapeutics
SMMT
$13.5B
| $47K | ﹤0.01% |
11,457
-21,838
| -66% | -$89.6K |
|
5030
Syndax Pharmaceuticals
SNDX
$1.3B
| $47K | ﹤0.01% |
1,986
-17,376
| -90% | -$411K |
|
5031
Driven Brands
DRVN
$2.84B
| $46K | ﹤0.01% |
2,903
+803
| +38% | +$12.7K |
|
5032
iShares MSCI Indonesia ETF
EIDO
$318M
| $46K | ﹤0.01% |
2,025
-2,306
| -53% | -$52.4K |
|
5033
Franklin FTSE Europe ETF
FLEE
$118M
| $46K | ﹤0.01% |
1,556
+1,456
| +1,456% | +$43K |
|
|
NXDR
5034
Nextdoor Holdings
NXDR
$840M
| $46K | ﹤0.01% |
20,067
-27,246
| -58% | -$62.5K |
|
5035
Kymera Therapeutics
KYMR
$3.49B
| $46K | ﹤0.01% |
1,136
-10,718
| -90% | -$434K |
|
5036
ProShares K-1 Free Crude Oil Strategy ETF
OILK
$71.5M
| $46K | ﹤0.01% |
953
+791
| +488% | +$38.2K |
|
5037
Zentalis Pharmaceuticals
ZNTL
$102M
| $46K | ﹤0.01% |
2,882
-14,645
| -84% | -$234K |
|
|
INBX
5038
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $46K | ﹤0.01% |
1,324
-14,669
| -92% | -$510K |
|
5039
AllianzIM US Large Cap Buffer20 Apr ETF
APRW
$175M
| $45K | ﹤0.01% |
1,482
| – | – |
|
5040
Cadre Holdings
CDRE
$1.34B
| $45K | ﹤0.01% |
1,235
-4,248
| -77% | -$155K |
|
|
EU
5041
enCore Energy
EU
$470M
| $45K | ﹤0.01% |
10,329
-50,900
| -83% | -$222K |
|
5042
HealthStream
HSTM
$860M
| $45K | ﹤0.01% |
1,690
-6,541
| -79% | -$174K |
|
5043
Invesco KBW Regional Banking ETF
KBWR
$51.9M
| $45K | ﹤0.01% |
880
-557
| -39% | -$28.5K |
|
|
QIPT
5044
Quipt Home Medical
QIPT
$114M
| $45K | ﹤0.01% |
10,355
-12,543
| -55% | -$54.5K |
|
5045
ARKO Corp
ARKO
$573M
| $44K | ﹤0.01% |
7,730
-13,552
| -64% | -$77.1K |
|
|
GP
5046
GreenPower Motor Co
GP
$10.3M
| $44K | ﹤0.01% |
22,213
+7,782
| +54% | +$15.4K |
|
5047
Marcus & Millichap
MMI
$1.24B
| $44K | ﹤0.01% |
1,293
-7,830
| -86% | -$266K |
|
5048
Cartesian Therapeutics
RNAC
$250M
| $44K | ﹤0.01% |
2,218
-1,622
| -42% | -$32.2K |
|
5049
Sight Sciences
SGHT
$183M
| $44K | ﹤0.01% |
8,144
-4,595
| -36% | -$24.8K |
|
5050
SIGA Technologies
SIGA
$644M
| $44K | ﹤0.01% |
5,111
-8,467
| -62% | -$72.9K |
|